Open Payments Expansion Act

This bill requires pharmaceutical and medical device manufacturers to publicly disclose payments made to patient advocacy organizations starting in 2026. Manufacturers must report the name of the organization and payment amount annually by March 31 each year, including indirect payments directed through third parties. It specifically covers 501(c)(3) organizations that provide patient education, advocacy, or support services related to diagnosed medical conditions. The disclosure applies to all payments or transfers of value, whether direct or indirect, to these patient-focused groups.